BTX 1503
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BTX 1503, covering 2022-04-18 to 2022-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris [Phase 2]